These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2616978)

  • 21. A multicenter double-blind evaluation of ketoconazole in the treatment of dermatomycoses.
    Jolly HW; Daily AD; Rex IH; Krupp I; Tromovitch TA; Stegman SJ; Glogau R
    Cutis; 1983 Feb; 31(2):208-10, 212-3 passim. PubMed ID: 6299652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic injury associated with ketoconazole therapy. Analysis of 33 cases.
    Lewis JH; Zimmerman HJ; Benson GD; Ishak KG
    Gastroenterology; 1984 Mar; 86(3):503-13. PubMed ID: 6319220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ketoconazole-induced fulminant hepatitis necessitating liver transplantation.
    Knight TE; Shikuma CY; Knight J
    J Am Acad Dermatol; 1991 Aug; 25(2 Pt 2):398-400. PubMed ID: 1832694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ketoconazole-induced acute liver necrosis].
    Krivoy N; Bassan L
    Harefuah; 1986 Apr; 110(7):346-7. PubMed ID: 3732948
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hepatic lesions induced by drugs. Report of 26 cases].
    Olmos M; Guma C; Colombato LO; Lami G; Miyashiro R; Alvarez E
    Acta Gastroenterol Latinoam; 1987; 17(2):105-11. PubMed ID: 3442185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ketoconazole hepatotoxicity in a patient treated for environmental illness and systemic candidiasis.
    Brusko CS; Marten JT
    DICP; 1991 Dec; 25(12):1321-5. PubMed ID: 1815425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The yellow peril].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1985 Jul; 129(30):1414-6. PubMed ID: 4047189
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hepatic toxicity of ketoconazole].
    Domingo Ribas C; Martí Ripoll S; Raventós Vilaplana A; Cabezuelo Hernández MA
    Rev Clin Esp; 1987 Dec; 181(9):542. PubMed ID: 3448668
    [No Abstract]   [Full Text] [Related]  

  • 29. [Toxic hepatitis caused by ketoconazole (Nizoral)].
    Boëtius G; Peeters JP; Peters JH
    Ned Tijdschr Geneeskd; 1983 Feb; 127(8):341-3. PubMed ID: 6300702
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapeutic experience with ketoconazole.
    Difonzo EM; Palleschi GM; Vannini P; Panconesi E
    Drugs Exp Clin Res; 1986; 12(5):397-403. PubMed ID: 3720524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Histopathologic observations on acute liver lesions in patients taking Nizoralt (ketokonazol)].
    Kendrey G; Kovács M
    Morphol Igazsagugyi Orv Sz; 1988 Oct; 28(4):292-7. PubMed ID: 3185578
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hepatotoxicity caused by ketoconazole].
    Cabeza Lamban F; Simal Gil E; Mur Villacampa M; Guerrero Navarro L
    Rev Esp Enferm Apar Dig; 1989 Jul; 76(1):92. PubMed ID: 2799042
    [No Abstract]   [Full Text] [Related]  

  • 33. [Ketoconazole hepatoxicity. Apropos of a case].
    Caballería Rovira E; Massó Ubeda RM; Aragó López JV; Sanchis Closa A
    Med Clin (Barc); 1986 Feb; 86(7):303-4. PubMed ID: 3713348
    [No Abstract]   [Full Text] [Related]  

  • 34. [Liver damage during administration of itraconazole (Trisporal)].
    Lavrijsen AP; Balmus KJ; Nugteren-Huying WM; Roldaan AC; van 't Wout JW; Stricker BH
    Ned Tijdschr Geneeskd; 1993 Jan; 137(1):38-41. PubMed ID: 8380490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ketoconazole--a change in antimycotic therapy?].
    Meinhof W
    Hautarzt; 1983 Apr; 34(4):155-8. PubMed ID: 6303982
    [No Abstract]   [Full Text] [Related]  

  • 36. Ketoconazole and the liver: further considerations.
    Delpre G; Kadish U
    Gastroenterology; 1984 Oct; 87(4):985-6. PubMed ID: 6088353
    [No Abstract]   [Full Text] [Related]  

  • 37. [Usefulness of ketoconazole combined with cyclosporin in renal transplantation].
    García R; Marín C; Herrera J; Henríquez La Roche C; Rubio L; Rodríguez-Iturbe B
    Invest Clin; 1991; 32(3):115-21. PubMed ID: 1814474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety aspects of ketoconazole, the most commonly used systemic antifungal.
    Cauwenbergh G
    Mycoses; 1989; 32 Suppl 2():59-63. PubMed ID: 2700224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ketoconazole-induced fulminant hepatitis.
    Bercoff E; Bernuau J; Degott C; Kalis B; Lemaire A; Tilly H; Rueff B; Benhamou JP
    Gut; 1985 Jun; 26(6):636-8. PubMed ID: 4007605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of severe or refractory dermatophytoses with ketoconazole. Report of a study conducted by 16 dermatologists in Quebec].
    Giroux JM
    Union Med Can; 1986 May; 115(5):314-7. PubMed ID: 3765195
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.